Clinical Trials Directory

Trials / Completed

CompletedNCT04840082

Optimal Length for Nasal Mid-turbinate and Nasopharyngeal Swabs

Optimal Insertion Length for Nasal Mid-turbinate and Nasopharyngeal Swabs for Respiratory Virus Infection Diagnostic Testing - a Clinical Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
109 (actual)
Sponsor
Rigshospitalet, Denmark · Academic / Other
Sex
All
Age
16 Years
Healthy volunteers
Accepted

Summary

This study aim to explore the optimal swap insertion length for mid-turbinate and nasopharyngeal samples. Our clinical trial took place at a Covid-19 test center in Copenhagen. Participants consisted of voluntary citizens who were at the test center for a nasopharyngeal antigen quicktest. An endoscopic examination was performed simultaneous with the swap to measure the length from the vestibulum nasi to the posterior wall of the nasopharynx and the mid-turbinate.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTNasopharyngeal swab for COVID-19 testingA nasopharyngeal swab was performed endoscopically video guided to measure the actual length from to the mid turbinate and the posterior nasopharyngeal wall

Timeline

Start date
2021-03-07
Primary completion
2021-03-08
Completion
2021-03-08
First posted
2021-04-09
Last updated
2021-04-09

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT04840082. Inclusion in this directory is not an endorsement.